Based in Orlando, Florida, AOI Medical, Inc. (“AOI” or the “Company”) is a medical device company focused on the development and commercialization of innovative orthopedic medical devices for the spine and trauma markets. The Company trades publicly on AIM under the symbol “AOI.L”, has a current market cap of $[38.6] million, and has research coverage (“Buy” ratings) from Numis Securities (“Numis”) and Edison Investment Research (“Edison”).
AOI has developed three orthopedic product platforms: Ascendx Vertebral Compression Fracture Reduction System (“Ascendx”), Motion Preserving Cervical Dynamic Stabilization Plate (“Cervical Plate”) and Balloon Assisted Management of Trauma Fractures (“BAMF Trauma”): MM Dillon acted as a placement agent in the company’s common stock sale to institutional investors.
About M.M. Dillon & Co.
M.M. Dillon & Co. (formerly CRT Investment Banking LLC) is an employee owned partnership where industry and product specialists collaborate closely to provide creative, idea-driven advice and solutions to its institutional and corporate clients. M.M. Dillon offers public and private financing, M&A advisory and restructuring advisory services. M.M. Dillon’s team of experienced professionals provides execution capabilities for companies across a range of industry sectors. The firm’s senior banking professionals have a minimum of 20 years of experience with major Wall Street firms.